Collegium Pharmaceutical's total assets for Q4 2025 were $1.66B, an increase of 3.08% from the previous quarter. COLL total liabilities were $1.36B for the fiscal quarter, a 1.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.